• No results found

Pharmacokinetics and/or pharmacodynamics of propofol, atracurium and cefazolin in morbidly obese patients Kralingen, S. van

N/A
N/A
Protected

Academic year: 2021

Share "Pharmacokinetics and/or pharmacodynamics of propofol, atracurium and cefazolin in morbidly obese patients Kralingen, S. van"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Citation

Kralingen, S. van. (2011, June 23). Pharmacokinetics and/or

pharmacodynamics of propofol, atracurium and cefazolin in morbidly obese patients. Retrieved from https://hdl.handle.net/1887/17732

Version: Corrected Publisher’s Version License:

Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/17732

Note: To cite this publication please use the final published version (if applicable).

(2)

Pharmacokinetics and/or pharmacodynamics of propofol, atracurium and cefazolin in morbidly obese patients

Simone van Kralingen

(3)

The printing of this thesis was financed by the section Anaesthesiology, Intensive Care and Pain Medicine of the St. Antonius Hospital, Nieuwegein, The Netherlands

Cover design: iStockphoto.com

Lay-out and printing: Gildeprint Drukkerijen - Enschede, The Netherlands ISBN 978-94-6108-166-7

© 2011 Simone van Kralingen, Amsterdam. All rights reserved. No parts of this publication may be reproduced, stored in a retrieval system of any system of any nature, or transmitted in any part or by any means without the prior written permission of the holder of the copyright.

(4)

Pharmacokinetics and/or pharmacodynamics of propofol, atracurium and cefazolin in morbidly obese patients

Proefschrift

Ter verkrijging van de graad van Doctor aan de Universiteit Leiden, op gezag van de Rector Magnificus prof. mr. P.F. van der Heijden,

volgens besluit van het College voor Promoties te verdedigen op donderdag 23 juni 2011

klokke 11.15 uur

door

Simone van Kralingen geboren te Hilversum in 1977

(5)

St. Antonius Ziekenhuis, Nieuwegein Dr. B. van Ramshorst

St. Antonius Ziekenhuis, Nieuwegein Overige leden: Prof. dr. M. Danhof

Leiden / Amsterdam Center for Drug Research, LACDR Prof. dr. A.P. IJzerman

Leiden / Amsterdam Center for Drug Research, LACDR Prof. dr. A. Dahan

Leids Universitair Medisch Centrum, LUMC Prof. dr. H.J. Guchelaar

Leids Universitair Medisch Centrum, LUMC Prof. dr. J.T.A. Knape

Universitair Medisch Centrum Utrecht, UMCU

(6)

Aan Rutger Aan mijn ouders

(7)
(8)

Contents

Section I General introduction

Chapter 1 Pharmacokinetics and/or pharmacodynamics 11 of propofol, atracurium and cefazolin in morbidly

obese patients

Chapter 2 Scope and intent of the investigations 31 Section II Propofol in morbidly obese patients

Chapter 3 Comparative evaluation of propofol 350 mg and 45 200 mg for induction of anaesthesia in morbidly

obese patients: a randomised double blind pilot study Chapter 4 Maintenance of anaesthesia in morbidly obese patients 61

using propofol with continuous BIS-monitoring:

a comparison of propofol-remifentanil and propofol- epidural anaesthesia

Chapter 5 Population pharmacokinetics and pharmacodynamics 85 of propofol in morbidly obese patients

Section III Atracurium in morbidly obese patients

Chapter 6 Comparative evaluation of atracurium dosed on 115 ideal body weight versus total body weight in morbidly obese patients

Section IV Cefazolin in morbidly obese patients

Chapter 7 Pharmacokinetics and protein binding of cefazolin 133 in morbidly obese patients

(9)

Samenvatting (Synopsis in Dutch) 175

Nawoord (Epilogue in Dutch) 195

Curriculum Vitae (in Dutch) 199

List of publications 201

Referenties

GERELATEERDE DOCUMENTEN

33,34 For morbidly obese patients in comparison with nonobese healthy volunteers, the reduced hepatic CYP3A activity (1.52; range, 1.40–1.64; reduced CL int,H ) found in this

trough concentrations at day 3 based on Monte Carlo simulation in obese patients, using the final model, coloured by individual body weight, volume of distribution (V1) and

In this study with 20 morbidly obese individuals and eight non-obese individuals with body weights from 53 to 221 kg and normal renal function, we found that body weight is

To cite this article: FJ Smith, FX Jurgens, JF Coetzee & PJ Becker (2019) Induction of anaesthesia with propofol according to the adjusted ideal body mass in obese and

The data demonstrate a significant decrease in body weight, BMI, and leg volumes in morbidly obese end-stage primary, secondary, and obesity- induced LE patients following

55 figure 4 Effect of atracurium expressed as time to recovery of the twitch response of the neuromuscular train­of­four (TOF) to 5% versus dose for morbidly obese patients dosed

micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients. Jullien V, Azoulay E, Schwebel C